Back to courses

MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026-Archive

Description

This activity provides on-demand archived lectures from the MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 series. The MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 sessions are designed to increase knowledge among clinicians in an interprofessional setting about controlled substance risk assessment and current evidence-based care models for chronic pain and accessing pain care across underserved populations. We hope to close professional practice gaps utilizing interdisciplinary collaboration, education and training, community engagement, policy and advocacy, and research and innovation.

 

Course Directors
Ronald Kulich PhD & Thomas Cheng, MD, PhD  & Roxanne Bavarian. DMD, DMSc  & Michael E. Schatman, PhD & Matthew G. Fortino, PsyD & Elizabeth Hatfield, DDS  & David Alexander Keith, DMD, BDS & Christopher Robinson, MD, PhD

Coordinator:
Ascher Kulich

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at mgbcpd@mgb.org.

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.

Target audience

This activity is intended for Physicians, dentists, psychologists, nurses, students, residents, fellows with specialties of Oral surgery, Orofacial Pain, Pain Medicine and Sleep Medicine.

Learning objectives

Upon completion of this activity, participants will be able to:

  1. Identify patients with substance use disorders based on current data on overdose. Participants will be able to state at least two ways the clinician can curb the over-prescription of opioids for pain.
  2. Use the Prescription Drug Monitoring Program (PDMP) and identify other available screeners for substance misuse.
  3. List at least one strategy involved and/or resource available to help manage patients with substance misuse, with particular reference to underserved practice groups.
  4. Recognize three components of interprofessional care that predict improved patient outcomes.
  5. Summarize one way learning from or with an interprofessional team benefits the patient when treating substance use disorders.

Additional information

Mass General Brigham

Faculty credentials

Course Directors
Ronald Kulich PhD
Thomas Cheng, MD, PhD
Roxanne Bavarian. DMD, DMSc
Michael E. Schatman, PhD
Matthew G. Fortino, PsyD
Elizabeth Hatfield, DDS
David Alexander Keith, DMD, BDS
Christopher Robinson, MD, PhD

 

MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. All reviewers have no relevant relationships with ineligible companies.

 

The following planners have reported no relevant financial relationship with an ineligible company:

Roxanne Bavarian. DMD, DMSc
Gary Brenner, MD, PhD
Jennifer Cheng, CNP
Thomas Cheng, MD, PhD
Kathryn Dolan, RDH
Matthew G. Fortino, PsyD

Elizabeth Hatfield, DDS
Mohammed A. Issa, MD
David Alexander Keith, DMD, BDS
Anna Kim, RN
Ronald Kulich PhD
Robert
Nersasian , DMD

Christopher Robinson, MD, PhD
Michael E. Schatman, PhD
Michael A. Scialabba, DDS
Christine Sieberg, PhD 
Donna Sultan, MBA

Yuanming Xu, DDS, MMSc
Yi Zhang, MD, PhD

 

The following planners have reported a relevant financial relationship with an ineligible company:
Robert Jason Yong, MD, MBA

Consultant: Medtronic, Boston Scientific, Nevro, Biotronik, Abbot

Carol Warfield, MD
Consultant: Abbvie, Johnson & Johnson (ended)

Accreditation

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dentist
Mass General Brigham is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Mass General Brigham designates this activity for 1 continuing education credit.

Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Psychology

1 Continuing Education (CE) credit are awarded

 


*Some sessions in this activity are designed to meet the criteria for risk management study in Massachusetts.

Program

 

Date of Live Session Subject Speaker

September 17, 2025 

MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026: Introductory Keynote Presentation: Discovery, First Demonstration and Dissemination of Ether at MGH, 1846

Leonard Kaban, DMD, MD, FACS

September 24, 2025

The Future of Pain Medicine and Pain Care in the United States: Where We Are, Where We Need to Go

Antje M. Barreveld, MD
October 1, 2025

Health, Equity, and Pain Care

Jaleesa Jackson, MD
October 8, 2025

Neurosurgical Considerations for the Treatment of Trigeminal Neuralgia

Chetan Bettegowda, MD, PhD
October 15, 2025

19th Century Women Physicians Treating Pain: Bias, Bigotry, and the Men Who Supported Their Training

Ronald Kulich, PhD
October 22, 2025

Substance Use Disorder Assessment and Care for Medically Underserved Populations (MUPS)

Matthew Fortino, PsyD
October 29, 2025

Orofacial Pain and Sleep Comorbidity Interplay

Gilles Lavigne, DMD, MSc, PhD, FRCD
November 5, 2025

The Eternal Debate About the Utility of Spine Injections

Jane Ballantyne, MD, FRCA
November 12, 2025

New Headache Treatments: Evidence, Affordability, and Accountability

Elizabeth Loder, MD, MPH
November 19, 2025

HC-sparing Effects of Cannabis Constituents: Potential to Reduce Harms and Improve Outcomes

Ziva D. Cooper, PhD
December 3, 2025

Sleep Disorders and Pain

Patrick Finan, PhD
December 10, 2025

Surgical Management of Trigeminal Neuralgia

Jeffrey Schweitzer, MD, PhD
December 17, 2025

Junk Science, Evidence, and the Management of Pain

Jonathan Jarry, MSc
January 7, 2026

Electromyography in the Content of Pain Assessment

Reza Seyedsadjadi, MD
January 14, 2026

Pain in Head and Neck Cancer

Khawaja Shehryar Nasir, BDS
January 21, 2026

Update on Current Evidence of Cannabis Use for Pain

Paul Christo MD, MBA
January 28, 2026

The Role of Adaptive Sports in Chronic Pain

Jennifer Packard, OTRL/L
February 4, 2026

Elderly and Pain Medicine

Christine Ritchie, MD, PhD
February 11, 2026

Current Status of Pain Medicine and the Construct of Spectrum Disorders

Daniel Clauw, MD
February 18, 2026

The ‘4 Ps’ of Pain Medicine: Patients, Providers, Payers, and Profits

Michael Schatman, PhD
February 25, 2026

Post-traumatic Trigeminal Neuropathy

Tara Renton BDS, MDSc, PhD
March 4, 2026

Relevance Based Prediction (RBP) for Spinal Cord Stimulation Outcomes

Mark Kritzman
March 11, 2026

Pharmacotherapies for Migraine: Bench to Bedside

Messoud Ashina, MD, PhD, DMS
March 18, 2026

Diagnosis of Overlapping Orofacial Pain Diseases and Disorder

Donald Nixdorf, DDS, MS
March 25, 2026

Basic Mechanisms in Migraines

Sait Ashina, MD
April 1, 2026

April Fools’: Regenerative Medicine: A Prank or Reality

Christopher Robinson, MD, PhD
April 8, 2026

Evidenced-Based PT Approaches to Pain

Moreza Bahar, BPT, DPT, MSc
April 15, 2026

Immune Modulation for Neuropathic Pain: Translational Insights from Spinal Cord and Peripheral Nerve Stimulation

Eellan Sivanesan, MD, FASA
April 22, 2026

Pharmacogenetics of Orofacial Pain

Amy Pasternak, DMD
April 29, 2026

Retracted Publications in Pain Medicine

Michael Ferraro, BSc (Hons), BHSc and Neil O’Connell, PhD, MSc, BSc (Hons), PGCert
May 6, 2026

Sickle Cell and Pain

Robert Jason Yong, MD, MBA
May 13, 2026

Pediatric Obstructive Sleep Apnea (OSA)

Mitchell Levine, DMD, CAGS, MS
May 20, 2026

Spine and Musculoskeletal Pain Conditions

Zachary McCormick, MD
May 27, 2026

Management of Opioid Use Disorder (OUD) and Pain

Samata Sharma, MD
Course Summary
Skip to content
Office of Continuing Professional Development
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.